Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/25/2010 | CA2797937A1 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
11/25/2010 | CA2764931A1 Engineered type iv pilin of clostridium difficile |
11/25/2010 | CA2763151A1 N- [(2'r) -2'-deoxy-2'-fluoro-2' -methyl-p-phenyl-5' -uridylyl] -l-alanine 1-methylethyl ester and process for its production |
11/25/2010 | CA2763122A1 Bimacrocyclic hcv ns3 protease inhibitors |
11/25/2010 | CA2762640A1 Medication for oral administration, comprising at least one estrogen and/or at least one gestagen and at least one probiotic bacterial strain |
11/25/2010 | CA2762587A1 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof |
11/25/2010 | CA2762302A1 Compositions and methods for the therapy and diagnosis of influenza |
11/25/2010 | CA2761279A1 Heterocyclic antiviral compounds |
11/25/2010 | CA2760765A1 Disaccharin, difumaric acid, di-1-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamino)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin-5-yl) methyl) phenyl)acetate |
11/24/2010 | EP2253709A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
11/24/2010 | EP2253706A2 Antisense modulation of kinesin-like 1 expression |
11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
11/24/2010 | EP2253639A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
11/24/2010 | EP2253633A1 Fused heterocyclic compound |
11/24/2010 | EP2253621A1 A set of geldanamycin derivatives and their preparation methods |
11/24/2010 | EP2253325A1 Agent for enhancing corneal epithelial barrier function |
11/24/2010 | EP2253317A2 Triazol compounds for treating biofilm formation |
11/24/2010 | EP2252629A2 Use of defensins against tuberculosis |
11/24/2010 | EP2252615A1 Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists |
11/24/2010 | EP2252323A2 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
11/24/2010 | EP2252319A2 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof |
11/24/2010 | EP2252308A1 Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci |
11/24/2010 | EP2252291A1 Pharmaceutical composition |
11/24/2010 | EP2252287A1 Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics |
11/24/2010 | EP2252275A2 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
11/24/2010 | EP2252148A1 Methods for treating bowel diseases |
11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
11/24/2010 | EP1527088B1 Pegylated t20 polypeptide |
11/24/2010 | EP1502949B1 Antimicrobial polypeptide and utilization thereof |
11/24/2010 | EP1496742B1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
11/24/2010 | EP1355919B1 Molecules with extended half-lives, compositions and uses thereof |
11/24/2010 | EP1075186B1 Method of hsv prophylaxis |
11/24/2010 | CN1970020B A pharmaceutical composition, preparation process and application thereof |
11/24/2010 | CN1951932B [N-(3',4'methylenedioxy)phenylethyl] formamidobenzoic acid derivative, its preparation method and uses |
11/24/2010 | CN1947796B Chemical modified adefovir and tynofovir |
11/24/2010 | CN1919870B Cat alpha interferon, encode gene and application thereof |
11/24/2010 | CN1745849B Human bivalent purified hydrophobia vaccine and its preparation |
11/24/2010 | CN1513553B Vero cell fick-borne encephalitis inactivated vaccine |
11/24/2010 | CN101896595A Bactericidal cleanser composition |
11/24/2010 | CN101896497A Antiviral agents |
11/24/2010 | CN101896197A Novel polysaccharide immunogens from clostridium difficile |
11/24/2010 | CN101892252A Gene for encoding muramidase and application of same |
11/24/2010 | CN101892249A Pufa polyketide synthase systems and uses thereof |
11/24/2010 | CN101892200A Anti-H3N8 subtype equine influenza virus monoclonal antibody and application thereof |
11/24/2010 | CN101892198A Anti-anthrax lethal factor chimeric monoclonal antibody, and preparation method and application thereof |
11/24/2010 | CN101892188A Live lactobacillus acidophilus preparation and preparation method and application thereof |
11/24/2010 | CN101892181A Streptoseomycin and preparation method and application thereof |
11/24/2010 | CN101892177A Antifungal lipopeptid-containing skin liniment and preparation method thereof |
11/24/2010 | CN101892176A Microbe generating antifungal lipopeptid and preparation method and application of antifungal lipopeptid thereof |
11/24/2010 | CN101892175A Bovine capsular serotype A Pasteurella mutocida, validation identification and application thereof |
11/24/2010 | CN101891836A Method for extracting white mushroom lentinan assisted with ultrasonic wave |
11/24/2010 | CN101891833A Method for preparing carboxymethyl maca polysaccharide |
11/24/2010 | CN101891825A Recombinant fusion proteins of hepatitis B core proteins and tuberculosis antigen or antigen fragments and application thereof |
11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
11/24/2010 | CN101891806A Anti-flavivirus envelope E protein monoclonal antibody and application thereof |
11/24/2010 | CN101891805A Human enterovirus 71 type specific polypeptide and application thereof |
11/24/2010 | CN101891804A Antisense peptide nucleic acid of cell penetrating peptide-mediated antibacterial RNA polymerase sigma 70 factor gene rpoD |
11/24/2010 | CN101891785A Extraction method of hyperin and application thereof in medicament preparation |
11/24/2010 | CN101891752A Prodrug of DCK (deoxycytidine kinase) analogue, preparation method and application thereof |
11/24/2010 | CN101891705A 4-alkyl-6-aryl-2-acylamino-1,3-thiazine-5-formic ether, and preparation method and application thereof |
11/24/2010 | CN101891680A Modulators of atp-binding cassette transporters |
11/24/2010 | CN101890169A Moxifloxacin oral preparation and preparation method thereof |
11/24/2010 | CN101890167A Conveniently implantable sustained release drug compositions |
11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
11/24/2010 | CN101890161A Oligonucleotide composition adjuvant |
11/24/2010 | CN101890160A Multivalent recombinant human papilloma virus vaccine and application thereof |
11/24/2010 | CN101890159A Method for preparing bivalent inactivated vaccine of tilapia streptococcus |
11/24/2010 | CN101890144A Medicament for treating hepatitis B and preparation method |
11/24/2010 | CN101890143A Callicarpa nudiflora galangal composite washing liquid, preparation method and application thereof |
11/24/2010 | CN101890140A Chinese medicinal herb for preventing and treating foot-and-mouth diseases |
11/24/2010 | CN101890126A Decoction for treating urinary tract infection |
11/24/2010 | CN101890123A Method for preparing externally applied agent for treating appendicitis |
11/24/2010 | CN101890120A Qinggan capsules |
11/24/2010 | CN101890114A Li nation medicament extract and composition with bacteriostatic, anti-inflammatory and hemostasis effects and preparation method thereof |
11/24/2010 | CN101890096A Chinese medicinal composition for treating dermatophytosis |
11/24/2010 | CN101890066A Method for constructing Bidens parviflor willd medicinal material capillary electrophoresis fingerprint and application thereof |
11/24/2010 | CN101890059A Hepatitis B virus resistant active composition of polyprenols from ginkgo biloba leaves and preparation method thereof |
11/24/2010 | CN101890057A Chinese brake herb preparation for treating gastrointestinal tract and urinary tract infections and cardiovascular and cerebrovascular diseases and preparation method thereof |
11/24/2010 | CN101890048A Total bile acid extract of bear bile powder and preparation method and application of injection thereof |
11/24/2010 | CN101890039A Composite medicament used for treating herpes zoster |
11/24/2010 | CN101890038A Nuezhenoside-rhoifolin-hyperin composite and application in medicinal preparation thereof |
11/24/2010 | CN101890037A Nuezhenoside and hyperin composition and application thereof for preparing medicine |
11/24/2010 | CN101890030A Composite capable of preventing bacteria, viruses, oxidation and pigment deposition |
11/24/2010 | CN101890028A Stabilized pharmaceutical composition |
11/24/2010 | CN101890023A Cefuroxime axetil oral liquid and preparation method thereof |
11/24/2010 | CN101890022A Cefoperazone sodium and tazobactam sodium medicament composition liposome injection |
11/24/2010 | CN101890021A Cefozopran hydrochloride for injection and preparation method thereof |
11/24/2010 | CN101890020A Composition of cephapirin sodium and potassium clavulanate and proportion thereof |
11/24/2010 | CN101890016A Piperacillin sodium-tazobactam sodium medicinal composition microsphere injection |
11/24/2010 | CN101890015A Liposome injection of pharmaceutical composition comprising piperacillin sodium and tazobactam sodium |
11/24/2010 | CN101890014A Piperacillin-sulbactam sodium medicinal composition liposome injection |
11/24/2010 | CN101890008A Amoxicillin sodium/sulbactam sodium composition microsphere injection |
11/24/2010 | CN101890007A Amoxicillin sodium potassium clavulanate composition microballoon injection |
11/24/2010 | CN101890006A Amoxicillin sustained-release preparation composition and preparation method thereof |
11/24/2010 | CN101890005A Amoxicillin/clavulanate potassium enteric-coated preparation composition and preparation method thereof |
11/24/2010 | CN101890004A Amoxicillin/potassium clavulanate sustained-release preparation composition and preparation method thereof |
11/24/2010 | CN101890003A Method for preparing novel chlorhexidine acetate cream |
11/24/2010 | CN101890002A Application of phenylpropylthiophene derivative in preparation of anti-HIV medicament |
11/24/2010 | CN101889995A Drug application of 4-((3-(((2-naphthoxy)acetyl)hydrazo)butyryl)amine) benzamide |
11/24/2010 | CN101889992A Application of 2,4-dihydroxy benaophenonel in preparing medicament for treating hepatitis |